BIOT
NASDAQBiotech Acquisition Company
Price$0.43+0.03 (+7.35%)
01:30 PM07:45 PM
News · 26 weeks9+100%
2026-02-082026-08-02
Mix890d
- Other5(63%)
- SEC Filings3(38%)
Latest news
25 items- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- PRBIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics MarketsNEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ:BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese aesthetic healthcare brand "GENRÊVER CLINIC" to Indonesia and, together with a local Indonesian physician, to launch a subscription-model membership beauty clinic business. The proposed business model is expected to offer customers a flat-fee membership structure with flexible cancellation terms. The Company believes that this subscription-based membership model represents a differentiated offering in the Indonesian aesthetic clinic market. The Company intends to explore opportunities in Ind
- SECSEC Form 20-F filed by Biotech Acquisition Company20-F - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form 6-K filed by Biotech Acquisition Company6-K - INSTINCT BIO TECHNICAL CO HOLDINGS INC. (0002072188) (Filer)
- SECSEC Form CERT filed by Biotech Acquisition CompanyCERT - Relativity Holdings Inc. (0002072188) (Filer)
- PRInstinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026New York, NY, Las Vegas, NV, Tokyo, JP, July 23, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. ("Instinct Bio," "BIOT," or the "Company"), the parent company of Instinct Bio Technical Company Inc, an integrated regenerative medicine and longevity company, and Relativity Acquisition Corp. (OTC:ACQC), a special purpose acquisition company, today jointly announced the successful completion of its previously announced business combination (the "Business Combination"). The milestone positions Instinct Bio into a publicly listed life sciences company and gives U.S. investors direct access to one of the most transformative frontiers in healthcare: the science of living lo
- SECSEC Form 8-A12B filed by Biotech Acquisition Company8-A12B - Relativity Holdings Inc. (0002072188) (Filer)
- SECSEC Form 424B3 filed by Biotech Acquisition Company424B3 - Relativity Holdings Inc. (0002072188) (Filer)
- SECSEC Form EFFECT filed by Biotech Acquisition CompanyEFFECT - Relativity Holdings Inc. (0002072188) (Filer)
- SECSEC Form POS AM filed by Biotech Acquisition CompanyPOS AM - Relativity Holdings Inc. (0002072188) (Filer)
- SECAmendment: SEC Form F-4/A filed by Biotech Acquisition CompanyF-4/A - Relativity Holdings Inc. (0002072188) (Filer)
- SECAmendment: SEC Form F-4/A filed by Biotech Acquisition CompanyF-4/A - Relativity Holdings Inc. (0002072188) (Filer)
- 13D/GSEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)SC 13G/A - Biotech Acquisition Co (0001825413) (Subject)
- SECSEC Form 15-12G filed by Biotech Acquisition Company15-12G - Biotech Acquisition Co (0001825413) (Filer)
- 13D/GSEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)SC 13G/A - Biotech Acquisition Co (0001825413) (Subject)
- 13D/GSEC Form SC 13G filed by Biotech Acquisition CompanySC 13G - Biotech Acquisition Co (0001825413) (Subject)
- 13D/GSEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)SC 13G/A - Biotech Acquisition Co (0001825413) (Subject)
- 13D/GSEC Form SC 13G/A filed by Biotech Acquisition Company (Amendment)SC 13G/A - Biotech Acquisition Co (0001825413) (Subject)
- SECSEC Form 25-NSE filed by Biotech Acquisition Company25-NSE - Biotech Acquisition Co (0001825413) (Subject)
- SECBiotech Acquisition Company filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Biotech Acquisition Co (0001825413) (Filer)
- NEWSReported Late Wednesday, Biotech Acquisition Company Announces Liquidation; Will Not Implement The Extension Of The Time Period The Company Has To Complete An Initial Business CombinationBiotech Acquisition Company (the "Company") (NASDAQ:BIOT), announced today that it will not implement the extension of the time period the Company has to complete an initial business combination as approved by its shareholders at an extraordinary general meeting of shareholders held on January 19, 2023 as a result of the investor being unable to deposit the requisite funds into the Company's trust account ("Trust Account") for the extension. As a result, the Company will dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association, as amended (the "Charter") and will redeem all of the outstanding ordinary shares that were include
- PRBiotech Acquisition Company Announces LiquidationNew York, New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the "Company") (NASDAQ:BIOT), announced today that it will not implement the extension of the time period the Company has to complete an initial business combination as approved by its shareholders at an extraordinary general meeting of shareholders held on January 19, 2023 as a result of the investor being unable to deposit the requisite funds into the Company's trust account ("Trust Account") for the extension. As a result, the Company will dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association, as amended (the "Charter") and will redeem
- 13D/GSEC Form SC 13G filed by Biotech Acquisition CompanySC 13G - Biotech Acquisition Co (0001825413) (Subject)
- SECBiotech Acquisition Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Biotech Acquisition Co (0001825413) (Filer)
BIOT FAQ
6 questionsWhat does Biotech Acquisition Company do?
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Where does BIOT stock trade?
Biotech Acquisition Company (BIOT) is listed on NASDAQ.What sector and industry is BIOT in?
Biotech Acquisition Company operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Biotech Acquisition Company go public?
Biotech Acquisition Company (BIOT) completed its IPO in 2021.What companies are similar to BIOT?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare BIOT side-by-side with any of them on Quantisnow.How can I track BIOT on Quantisnow?
Quantisnow aggregates Biotech Acquisition Company's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BIOT to receive live email and push alerts on every new disclosure.